Cargando…
Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency.
Dysregulation of the mammalian target of rapamycin (mTOR) signaling, which is mediated by two structurally and functionally distinct complexes mTORC1 and mTORC2, has been implicated in several neurological disorders(1-3). Individuals carrying loss-of-function mutations in the phosphatase and tensin...
Autores principales: | Chen, Chien-Ju, Sgritta, Martina, Mays, Jacqunae, Zhou, Hongyi, Lucero, Rocco, Park, Jin, Wang, I-Ching, Park, Jun Hyoung, Kaipparettu, Benny Abraham, Stoica, Loredana, Nejad, Paymaan Jafar, Rigo, Frank, Chin, Jeannie, Noebels, Jeffrey L., Costa-Mattioli, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082835/ https://www.ncbi.nlm.nih.gov/pubmed/31636454 http://dx.doi.org/10.1038/s41591-019-0608-y |
Ejemplares similares
-
mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors
por: Zhu, Ping Jun, et al.
Publicado: (2018) -
Targeted suppression of mTORC2 reduces seizures across models of epilepsy
por: Okoh, James, et al.
Publicado: (2023) -
mTORC2 controls actin polymerization required for consolidation of long-term memory
por: Huang, Wei, et al.
Publicado: (2013) -
Hyperactivity of mTORC1 or mTORC2-dependent signaling causes epilepsy downstream of somatic PTEN loss
por: Cullen, Erin R., et al.
Publicado: (2023) -
mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
por: Yang, Jin Young, et al.
Publicado: (2019)